By Kim Richters 
 

The French pharmaceutical major Sanofi SA said Friday that it is collaborating with Translate Bio Inc. to develop a new mRNA vaccine candidate against Covid-19.

The U.S. therapeutics company Translate Bio and Sanofi will research and develop "multiple candidates with the goal of advancing an efficacious and safe SARS-CoV-2 vaccine into clinical development," Sanofi said.

It is the second collaboration related to a new Covid-19 vaccine candidate for Sanofi after it in February started working with the Biomedical Advanced Research and Development Authority.

 

Write to Kim Richters at kim.richters@wsj.com

 

(END) Dow Jones Newswires

March 27, 2020 02:53 ET (06:53 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Historical Stock Chart
From Apr 2020 to May 2020 Click Here for more Sanofi Charts.
Sanofi (EU:SAN)
Historical Stock Chart
From May 2019 to May 2020 Click Here for more Sanofi Charts.